Plné znění - 2/2008 Sb. m. s.

Xxxxxxxxxxxx xxxxxxxxxxxx xxxx xxxxxxx, že xxx 16. xxxxxxxxx 2007 xxxx xxxxxxxxxx xxxxxxxxx UNESCO, xxxxxxxxxxx Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx ve xxxxxx¹⁾, xxxxxxxx xxxxxxxxx nového xxxxx Přílohy I - Xxxxxxx zakázaných xxxxx x metod xxxxxxx.

Xxxxxxx X xxxxxxxxx x platnost x xxxxxxx x článkem 34 xxxx. 3 Xxxxxx xxx 1. xxxxx 2008 x tímto xxxx vstoupila v xxxxxxxx x xxx Xxxxxx republiku. Xxxx xxxxxx Přílohy I x xxxxxxxx xxxxxxxx xxxxxx Příloha I Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx xx xxxxxx xx xxxxx xxx xxx 2007, xxxxxxxxx xxx x. 59/2007 Xx. x. x.

Xxxxxxxx xxxxx Xxxxxxx X a její xxxxxxx xx xxxxxxx xxxxxx xx vyhlašují xxxxxxxx.

X1. ANABOLICKÉ LÁTKY

Xxxxxxxxxx látky xxxx xxxxxxxx.

1. XXXXXXXXXX XXXXXXXXXX XXXXXXXX (AAS):

x. Xxxxxxxx * XXX, xxxxxxxxxx:

1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3β,17β-xxxx); 1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3,17-xxxx); xxxxxxxxx (19-norandrostendiol); xxxxxxxxxx; xxxxxxxx; xxxxxxx (xxxxxxxx-1,4-xxxx-3,17-xxxx); xxxxxxx (17α-ethynyl-17β-hydroxyandrost-4-eno[2,3-d]isoxazol); dehydrochlormethyltestosteron (4-xxxxxx-17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxxxxxxxxxxxxxxxx (17α-metyl-5α-androst-2-en-17β-ol); xxxxxxxxxxx; xxxxxxxxxxxxx (19-xxx-17α-xxxxx-4-xx-17-xx); xxxxxxxxxxxxxx; formebolon; xxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxxxxx[2,3-x]-xxxxxxx); gestrinon; 4-xxxxxxxxxxxxxxxxxx (4,17β-xxxxxxxxxxxxxxxx-4-xx-3-xx); xxxxxxxxxx; xxxxxxxxx; xxxxxxxxxx; mesterolon; metandienon (17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxx; xxxxxxxxxxx; xxxxxxxxxx (2α, 17α-xxxxxxx-5α-xxxxxxxxx-3-xx-17β-xx); xxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxx-4,9-xxxx-3-xx); xxxxxx-1-xxxxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxx-1-xx-3-xx); xxxxxxxxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxx-4-xx-3-xx); xxxxxxxxxxxxxxx (17β-hydroxy-17α-metylestra-4,9,11-trien-3-on); xxxxxxxxxxxxxxxxx; xxxxxxxxx; xxxxxxxxx; 19-xxxxxxxxxxxxxxxx (xxxx-4-xx-3,17-xxxx); norboleton; xxxxxxxxxxxxxx; xxxxxxxxxxxx; oxabolon; xxxxxxxxxx; xxxxxxxxxxx; xxxxxxxxxx; prostanozol ([3,2-x]xxxxxxx-5α-xxxxxxxxxxxxxx-17β-xxxxxxxxxxxxxxxxx); xxxxxxxxx; xxxxxxxxxx; xxxxxxxxx; 1-testosteron (17β-hydroxy-5α-androst-1-en-3-on); xxxxxxxxxxxxxxxxxxx (18α-homo-pregna-4,9,11-trien-17β-ol-3-on); trenbolon x xxxxx xxxxx x podobnou xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx.

x. Xxxxxxxxx ** XXX:

Xxxxxxxxxxxxx (androst-5-en-3β,17β-diol), xxxxxxxxxxxxx (xxxxxxx-4-xx-3,17-xxxx), xxxxxxxxxxxxxxxxxx, xxxxxxxxx (xxxxxxxxxxxxxxxxxxxxx, XXXX), xxxxxxxxxxx x následující xxxxxxxxxx x xxxxxxx:

5α-androstan-3α,17α-diol androst-5-en-3β,17α-diol

5α-xxxxxxxxx-3α,17β-xxxx 4-xxxxxxxxxxxxx (xxxxxxx-4-xx-3β,17β-xxxx)

5α-xxxxxxxxx-3β,17α-xxxx 5-xxxxxxxxxxxxx (xxxxxxx-5-xx-3,17-xxxx)

5α-xxxxxxxxx-3β,17β-xxxx xxx-xxxxxxxxxxxxxxxxxx

xxxxxxx-4-xx-3α,17α-xxxx 3α-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-4-xx-3α,17β-xxxx 3β-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-5-xx-3β,17α-xxxx 19-xxxxxxxxxxxxxx

xxxxxxx-5-xx-3α,17α-xxxx 19-xxxxxxxxxxxxxxxxx

androst-5-en-3α,17β-diol

V xxxxxxxxx, xxx xxxx xxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxxx xxxxxxxxx, xxxx xx mít xx xx, xx Xxxxxx obsahuje xxxx Xxxxxxxxx xxxxx x xxxx hlášen xxxxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx, xxxx xx xxxxxxxxxxx Xxxxxxxx látky nebo xxxxxx xxxxxxxxxx nebo xxxxxxxxxxx x/xxxx xxxx xx jakýkoli jiný xxxxxxxxx xxxxx xx Xxxxxx Xxxxxxxxx xxxxxxxx xxxxxxxxx xx xxxxxxx xxxxxx, xxxxx xx xxxxxxxx xxxxxxxxx u xxxx xxx, xx xxxxxxxxxx xxxxxxxx endogenní xxxxxxxx. Nebude xx xxx xx xx, xx Vzorek xxxxxxxx Xxxxxxxxx xxxxx v xxxxxxx xxxxxxx, xxxxx Xxxxxxxxx xxxxxxx, xx xx xxxxxxxxxxx Zakázané xxxxx nebo jejích xxxxxxxxxx nebo xxxxxxxxxx x/xxxx xxxxxxxxx xxxxx xx Vzorku Xxxxxxxxx xxxxxxxx xxxxxxxxxxxxx xxxx xxxxxxxxxxxx xxxxxx.

Xxxx xx mít xx xx, xx Xxxxxx Xxxxxxxxx xxxxxxxx Xxxxxxxxx xxxxx x laboratoř xxxxxxx Pozitivní xxxxxxxxxxx xxxxx xx xxxxx xxxxxxxxx a při xxxxxxxxx xxxxxxxxxxx, pokud xxx podle xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxx, xx xx Xxxxxxxx xxxxx xxxxxxxxxx původu. X xxxxxxx xxxxxxx xxxx xxxxx xxxxxxxx xxxxx xxxxxxx.

Když xx xxxxxxx xxxxxxxx xxxxxxx xxxxxxxx neodchylují xx xxxxxxx xxxxxx, které xx xxxxxxxx xxxxxxxxx x xxxx x xxxxx xxxxxxxxxx analytická xxxxxx (xxxx. XXXX) xxxxxxxxxxx xxxxxxxx xxxxx Xxxxxxxx xxxxx, xxx xxxxxxxx xxxxxx xxxxxxx Xxxxxxxx xxxxx, jako xxxx. xxxxxxxxx s xxxxxxxxxxx referenčními xxxxxxxxxxx xxxxxxx, xxxx xxxx xxxxxxxxx xxxxxxxxx poměr X/X xxxxx xxx xxxxx (4) xx xxxxx (1) x xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. IRMS) xxxxxxxxxxx xxxxxxxx původ xxxxx, xxxxxxx xxxxxxxxx Xxxxxxxxxxxxx organizace xxxxx xxxxxxx porovnáním xxxxxxxx xxxxxxxxxx xxxxx xxxx xxxxxxxxxx xxxxxxxxxx xxxxx.

Xx-xx xxxxxxxxxx xxxxxx xxxxx šetření, xxx xxxxxxxx xxxx xxxxxxxxxx xxxxxx xxxx xxxxxxxxx x ne xxxx xxxxxxxxx. Xxxxx xxxxxxxxx xxxxxxx, za xxxxxxx xxxxxxxxxx analytické xxxxxx (xxxx. XXXX) xxxxxxxx xxxxx Xxxxxxxx xxxxx, xxxx nutné provádět xxxxx xxxxxxx, a xxxx se xxx xx to, že Xxxxxx obsahuje Zakázanou xxxxx. Xxxxx nebyla xxxxxxx xxxxxxxxxx analytická xxxxxx (např. XXXX) x xxxxxx x xxxxxxxxx xxxxxxxxx 3 xxxxxxxxx xxxxx, xxxx xxxxxxx xxxxxxxxxxxxxx profil Xxxxxxxxx xxx, xx xxxx xxxxxxxxxx Xxxxxxxxxxxxxx xxxxxxxxxx x xxxxxxxxxxxxx 3 měsících třikrát xxxxxxxx xxx předchozího xxxxxxxx. Xxxxxxxx, který xxxxxxxxxx xxxx longitudinální xxxxxx, bude xxxxxx xxxx neobvyklý. Xxxxx xxxxxxxxxxxxxx profil Sportovce, xxxxxxxx následnými xxxxx, xxxx fyziologicky xxxxxxxx, xxxx se xxx xxxxxxxxx xx Xxxxxxxxx xxxxxxxxxxx nález.

V xxxxxxxx xxxxxxxx individuálních xxxxxxxxx může xxx x xxxx trvale xxxxxxx xxxxxxxx xxxxxxxxxxx xxxxxx ve xxxxxx xxxxxx xxxxxxxxxxxxx (xx/xx). Xxxxx xxxxxxxxx xxxxxx xxxxx nahlásila a xxxxxxx spolehlivé xxxxxxxxxx xxxxxx (např. XXXX) xxxxxxxxxxx xxxxxxxx xxxxx Xxxxxxxx látky, xxxx xxx xxxxxxxxx xxxxx xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxx (xxxxxxxxxx xxxxx).

Xxxxx laboratoř nahlásila Xxxxxxxxx laboratorní xxxxx 19-xxxxxxxxxxxxxxx, xxxx se xx xxxxxxxxx za xxxxxxx x xxxxxxxxxxx xxxxx exogenního původu Xxxxxxxx xxxxx. V xxxxxxx xxxxxxx xxxx xxxxx xxxxxxxx xxxxx xxxxxxx.

V případě, xx Sportovec nebude xxxxxxxxxxxxx xxx dalších xxxxxxxxx, xxxx xx xxx za xx, xx Vzorek Xxxxxxxxx xxxxxxxx Zakázanou látku.

2. Xxxxxxx xxxxxxxxxx xxxxx, zahrnující:

Xxxxxxxxxxx, xxxxxxxxxx modulátory xxxxxxxxxxxxx xxxxxxxxx (SARM), xxxxxxx, xxxxxxx, xxxxxxxxxx, xxx xx s xxxxxxxx xxxxx xx xx.

X2. XXXXXXX A XXXXXXXX XXXXX

Následující látky x xxxxxx xxxxxxxxxx xxxxxxx jsou xxxxxxxx:

1. Erytropoetin (XXX);

2. Růstový hormon (xXX), insulinu podobné xxxxxxx xxxxxxx (xxxx. XXX-1), xxxxxxxxxx xxxxxxx xxxxxxx (XXX);

3. Xxxxxxxxxxxxx (xxxx. LH, xXX), zakázané jen x xxxx;

4. Xxxxxxxx;

5. Xxxxxxxxxxxxxx

x xxxxx látky x xxxxxxxx chemickou xxxxxxxxxx nebo podobnými xxxxxxxxxxxx xxxxxx.

Pokud Xxxxxxxxx nemůže xxxxxxxx, xx xxxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxxx xx xxxxxxxxxxxx xxxxxx, xxxx xx mít za xx, xx Vzorek xxxxxxxx Zakázanou xxxxx (xxx xx xxxxxxx xxxx) v xxxxxxxxx, xxx koncentrace Xxxxxxxx xxxxx xxxx xxxxxx xxxxxxxxxx či xxxxxxxxxx x/xxxx příslušné xxxxxx xx Xxxxxx Xxxxxxxxx xxxxxxx xxxxxxxx xxxxxxx xxxxxxxx xxxxxxxx u xxxx xxx, že xxxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx.

Xxxxx laboratoř xxxxxxxxx, po užití xxxxxxxxxx xxxxxxxxxx xxxxxx, xx Zakázaná xxxxx xx xxxxxxxxxx původu, xxxx se xxx xx xx, xx Xxxxxx obsahuje Xxxxxxxxx xxxxx x bude xxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx.

X3. XXXX-2 XXXXXXXX

Xxxxxxx xxxx-2 xxxxxxxx xxxxxx xxxxxx X- x X-xxxxxxx jsou xxxxxxxx.

Xxxxxxxx jsou xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxxx, pro xxxxx xx xxx inhalaci xxxxx xxxxxxx zkrácené xxxxxxxxxxxx xxxxxxx.

I xxxx xxxx xxxxxxx xxxxxxxx xxxxx terapeutické xxxxxxx, xxxx xxxxx xxxxxxxxxxx (xxxxx xxxx xxxxxxxxxx) xxxxx než 1000 nanogramů x 1 xxxxxxxxx moči xxxxxxxxx xx Pozitivní xxxxxxxxxxx xxxxx, pokud Xxxxxxxxx neprokáže, xx xxxxxxxxxx výsledek xxx xxxxxxxx terapeutickým xxxxxxxx xxxxxxxxxxx x inhalaci.

X4. XXXXXXXXXXX X XXXXXXXXXX HORMONŮ

Xxxxxxxxxxx skupiny xxxx xxxxxxxx:

1. Xxxxxxxxxx xxxxxxxx, xxxxxxxxxx:

2. Selektivní modulátory xxxxxxxxxxxxx xxxxxxxxx (XXXX), xxxxxxxx:

3. Xxxxxxx antiestrogenní xxxxx xxxxxxxxxx:

4. Xxxxx xxxxxxxxxxxx funkce xxxxxxxxxx včetně xxxxxxxxxx xxxxxxxxxx, ale ne x xxxxxxxx pouze xx xx.

X5. XXXXXXXXX A XXXXXXX MASKOVACÍ LÁTKY

Xxxxxxxxx xxxxx xxxx xxxxxxxx. Xxxxxxxx:

Xxxxxxxxx*, xxxxxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxx alfa-reduktázy (např. xxxxxxxxxx, dutasterid), xxxxxxxxxxxxxxx (xxxx. xxxxxxx, xxxxxxx, xxxxxxxxxxxxxxxxx) x xxxxx xxxxx x xxxxxxxxx xxxxxxxxxxxx účinky.

Diuretika xxxxxxxx:

Xxxxxxxxxxxx, xxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxx, kanrenon, kyselina xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxx (xxxx. bendroflumethiazid, xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx), triamteren x další xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx nebo podobnými xxxxxxxxxxxx xxxxxx (xxxxx xxxxxxxxxxxx, xxxxx není xxxxxxxx).

* Xxxxxxxxxxxx xxxxxxx není xxxxxx, xxxxx moč Sportovce xxxxxxxx xxxxxxxxx ve xxxxxxx x prahovou xxxx podprahovou hladinou xxxx Zakázané xxxxx (xxxxx).

X1. XXXXXXXXX PŘENOSU XXXXXXX

Zakázané xx xxxxxxxxxxx:

M2. XXXXXXXX X FYZIKÁLNÍ XXXXXXXXXX

X3. XXXXXX DOPING

Xxxxxxxxxxxxxx xxxxxxx buněk, genů, xxxxxxxx xxxxxxxx, xxxx xxxxxxxxxx xxxxxxx xxxx, xxxxx mají schopnost xxxxxx sportovní xxxxx, xx xxxxxxxx.

X6. XXXXXXXXXXX

Xxxxxxx xxxxxxxxxxx (xxxxxx xxxx xxxxxx xxxxxxxxxx optických (X- a L-) xxxxxxx) jsou xxxxxxxx, x xxxxxxxx xxxxxxxx xxxxxxxxx x případě xxxxxx xxxxxxxx xxxxx x xxxxxxxxxxx zahrnutých xx Xxxxxxxxxxxxxx xxxxxxxx xxx xxx 2008.

Xxxxxxxxxxx xxxxxxxx:

Xxxxxxxxx, xxxxxxxxx**, xxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxx, amfetamin, xxxxxxxxxxx, xxxxxxxxxxxxxxx, bromantan, xxxxxxxxxx, xxxxxxxxxxxxxxxxx, xxxxxxx****, xxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxx, famprofazon, xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, fenkamfamin, xxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, fenproporex, xxxxxxxxx, 4-xxxxxxxxxxxxxx (karfedon), xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxx, xxxxx***, xxxxxxxxxxx, kokain, xxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxxxx (X-), xxxxxxxxxxxx****, xxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxx, modafinil, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxxxxxxxx, xxxxxxx, xxxxxxxxxxx, p-methylamfetamin, xxxxxxxxx, propylhexedrin, xxxxxxxxx, xxxxxxxxxx, strychnin, xxxxxxxxxxxxx x xxxxx xxxxx x xxxxxxxx chemickou xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx.

Xxxxxxxxxxxx neuvedené xxxxxxxx xxxx xxxxxxxx v xxxxx xxxxxx xxxx xxxxxxxxxx za xxxxxxxxxxx xxxxx xxxxx, pokud Xxxxxxxxx prokáže, xx xxxx xxxxxxxxx dostupnost x xxxxxxx xxxxxxxxx xxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx antidopingových xxxxxxxx, xxxx xx x xxx xxxxx pravděpodobnost, xx xxxx xxxxxxx xxxxxxxx xxxx dopingová xxxxx.

X7. XXXXXXXXX

Xxxxxxxxxxx narkotika xxxx xxxxxxxx:

Buprenorfin, xxxxxxxxxxxxx, diamorfin(heroin), xxxxxxxx x xxxx xxxxxxxx, xxxxxxxxxxx, xxxxxxx, xxxxxx, xxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxx.

S8. XXXXXXXXXXX

Xxxxxxxxxxx (xxxx. xxxxx, xxxxxxxxx) jsou xxxxxxxx.

S9. XXXXXXXXXXXXXXXXXXXX

Všechny glukokortikosteroidy xxxxxxxx xxxxxx, rektálně, xxxxxxxxxx xxxx xxxxxxxxxxxxx xxxxxxxx jsou zakázané. Xxxxxx užití vyžaduje xxxxxxxxxxxxx xxxxxxx.

Xxxx xxxxxxx injekční xxxxxxxx (xxxxxxxxxxxx, xx okolí xxxxxx, xx okolí xxxxxx, xxxxxxxxxx, xx xxxx) x inhalační xxxxxxxx xxxxxxxx zkrácenou xxxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxx xxxxxxxxx.

Xxxxxxx přípravky xxxxxxxx xx xxxxxx xxxxx (xxxxxx xxxxxxxxxxx/xxxxxxxxxx), xxxx, xxxxx, oční, xxxxxx xxxxx řitního otvoru, xxxxxxxx xxx x xxxxx nejsou zakázané x xxxxxxxxxx xxxxxx xxxxx xxxxxxxxxxxx xxxxxxx.

P1. XXXXXXX

Xxxxxxx (xxxxxx) xx xxxxxxxx xxxxx Xxx xxxxxxx x xxxxxxxxxxxxx sportech. Xxxxxxx xx xxxx xxxxxxxx xxxxxxxx xxxxxxxx a/nebo xxxxxxxx xxxx. Prahová xxxxxxx xxx xxxxxxxx xxxxxxxxxxx xxxxxxxx (xxxxxxxxxxxxx xxxxxxx) xx pro xxxxxx federaci xxxxxxx x xxxxxxxxx.

∙ Xxxxxxxxxxxx xxxxx (FIA) (0.10 g/l)

∙ Xxxxxx (XXX) (0.10 x/x)

∙ Xxxxxxx xxxxxx x parašutismus (XXX) (0.20 x/x)

∙ Xxxxxxxxxxx (FITA, XXX) (0.10 g/l)

∙ Xxxxxxx pětiboj (XXXX) xxx xxx xxxxxxxxxx xx xxxxxxxx (0.10 x/x)

∙ Motocyklový xxxxx (XXX) (0.10 x/x)

∙ Xxxxx xxxxxxxxxx (XXX) (0.30 g/l)

∙ Kuželky (IPC) (0.10 x/x)

X2. XXXX-XXXXXXXXX

Xxxxx xxxx jinak určeno, xxxx-xxxxxxxxx jsou zakázány xxxxx Při xxxxxxx x xxxxxxxxxxxxx xxxxxxxx.

∙ Xxxxxxxxxxxx xxxxx (XXX)

∙ Xxxxxxxx (XXXX)

∙ Xxxx (XXXX)

∙ Bridž (XXX)

∙ Xxxxxxx (XXX)

∙ Gymnastika (XXX)

∙ Jachting (XXXX) - "xxxxx xxxx" - xxx xxxxxxxxxxx

∙ Xxxxxxx (XXX)

∙ Letecké xxxxxx x xxxxxxxxxxxx (XXX)

∙ Xxxxxxxxxxx (XXXX, XXX) (xxxxxxxx xxxx Mimo xxxxxx)

∙ Lyžování (XXX) - xxxxx na xxxxxx x xxxxxxxxxxx xxxxxxxx-xxxxx x U-rampa, x xxxxxxxxx U-rampa x "big air"

∙ Xxxxxxx xxxxxxx (XXXX) - xxx xxxxxxxxxx xx střelbou

∙ Xxxxxxxxxxx xxxxx (XXX)

∙ Xxxxxxxx x xxxxxxx sporty (XXXX, XXX "xxxxx")

∙ Xxxxxxx (XXXX, XXX) (zakázané také Xxxx xxxxxx)

∙ Xxxxx motorismus (XXX)

∙ Zápas (XXXX)

Xxxx-xxxxxxxxx zahrnují následující xxxxx:

Xxxxxxxxxx, xxxxxxxxxx, xxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxx, xxxxxxxxxx, esmolol, xxxxxxxxx, karvedilol, xxxxxxxxx, xxxxxxxxxxx, metipranolol, xxxxxxxxxx, xxxxxxx, xxxxxxxxxx, xxxxxxxx, xxxxxxxxxxx, xxxxxxx, xxxxxxx, xxx xx x xxxxxxxx xxxxx xx xx

"Specifické xxxxx"* xxxx xxxxxxxxxxx xxxx:

∙ Xxxxxxx Xxxx-2 xxxxxxxx x inhalaci, xxxxx xxxxxxxxxxx (xxxxxxx xxxx xxxxxxxxxxx) při xxxxxxxx xxxxxx xxx 1000 xx/xx xxxx x clenbuterolu (xxxxxxx xx xxxxxxx X 1.2 Xxxxxxx anabolické xxxxx);

∙ Xxxxxxxxxx xxxx-xxxxxxxxx, xxxxxxxxxx;

∙ Xxxxx, kropropamid, xxxxxxxxxx, xxxxxxx, etamivan, xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxxxxxxx, meklofenoxát, x-xxxxxxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxx, ortetamin, xxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxx, sibutramin, xxxxxxxxxxxxx a všechna xxxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxx v oddíle X6, pro xxxxx Xxxxxxxxx xxxxxxx, xx xxxxxxx podmínky xxxxxxx x xxxxxx X6;

∙ Xxxxxxxxxxx;

∙ Xxxxxxx Xxxxxxxxxxxxxxxxxxxx;

∙ Xxxxxxx;

∙ Xxxxxxx Xxxx-xxxxxxxxx.

*"V Xxxxxxx xxxxx xxx xxxxxxxxxxx xxxxxxxxxx látky, xxxxx xxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx antidopingových pravidel, xxxxxxx jsou všeobecně xxxxxxxx v běžných xxxxxxxxx xxxxxxxxxxx, xxxx x nichž xx xxxxx pravděpodobnost, že xxxxx xxxxxxx zneužity xxxx xxxxxxxxx xxxxxxx." Xxxxxxxx xxxxxxxxxxxxxxx pravidla xxxxxxxxxx takovéto xxxxx xxxx znamenat xxxxxxx xxxxxx xx xxxxxxxxxxx, xx "...Xxxxxxxxx xxxx xxxxx xxxxxxxx, xx Xxxxxxx xxxxxxxxxx látky xxxxxx xxxxxxxxx ke xxxxxxx sportovního xxxxxx...".

Xxxxxx xxxxxxx x. 2/2008 Xx. x. x. nabyl xxxxxxxxx xxxx 31.1.2008.

Xxxxxx xxxxxxx x. 2/2008 Xx. x. x. xxx zrušen xxxxxxx xxxxxxxxx č. 8/2009 Sb. m. s. x xxxxxxxxx od 7.2.2009.

Znění xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx xxxxxxxx xxxxxxxx x xxxxxxxx není xxxxxxxxxxxxx, pokud se xxxx netýká xxxxxxxxx xxxxx shora xxxxxxxxx xxxxxxxx xxxxxxxx.